CSIMarket
 




Aligos Therapeutics Inc   (ALGS)
Other Ticker:  
 
 



ALGS Price to Sales Ratio (Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Sales Trailing 12 Months III. Quarter II. Quarter I. Quarter IV. Quarter III. Quarter
Price to Sales (TTM) Ratio current            2.71            2.67            4.00            3.67            4.85
Revenue TTM Y / Y Change 52.6 % 111.21 % 133.54 % 219.04 % - %
Revenue Y / Y Change -21.12 % 86.46 % 5.91 % 863.76 % 167.14 %
Stock performance to date 15.91 % -29.92 % -43.41 % 84.76 % -15.32 %

Price to sales ratio Comment
Aligos Therapeutics Inc 's current Price to sales ratio has increased due to shareprice growth of 15.91 %, from beginning of III. Quarter and due to Revenue contraction of -21.12 %, to Price to Sales of 2.71, from average Price to sales ratio in II. Quarter of 2.67.

Within Healthcare sector 13 other companies have lower Price to sales ratio.

What is Price to Sales Ratio?
Sales growth by Aligos Therapeutics Inc Segment

Price to sales ratio Company Ranking
Within: No.
Industry #0
Sector #14
S&P 500 #347






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com